Prescription drug · ANDA
Allopurinol NDC 69315-292
Allopurinol 300 mg/1 · Tablet · Oral · Leading Pharma, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69315-292-01 | 69315029201 | 100 TABLET in 1 BOTTLE (69315-292-01)Marketed from May 1, 2024 | |
| 69315-292-05 | 69315029205 | 500 TABLET in 1 BOTTLE (69315-292-05)Marketed from May 1, 2024 | |
| 69315-292-10 | 69315029210 | 1000 TABLET in 1 BOTTLE (69315-292-10)Marketed from May 1, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Allopurinol
- Generic name (nonproprietary)
- allopurinol
- Active ingredients
- Allopurinol — 300 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Leading Pharma, LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214443
- Marketing start
- Listing expires
- Other FDA classes
- Xanthine Oxidase Inhibitors (Mechanism)
- Identifiers
- Product ID 69315-292_227ef709-80a3-45e9-807a-2db8abee3a50SPL ID 227ef709-80a3-45e9-807a-2db8abee3a50
- Pharmacologic class
- Xanthine Oxidase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469315029201followed by a unit qualifier and the quantityPackage 69315-0292-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
Other NDCs under ANDA 214443
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Harman Finochem Limited | 82638-113 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Harman Finochem Limited | 82638-112 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | ST. MARY'S MEDICAL PARK PHARMACY | 60760-710 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Leading Pharma, LLC | 69315-291 |
| Allopurinol | Allopurinol 200 mg/1 | TabletOral | Leading Pharma, LLC | 69315-409 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-3672 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-2542 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Coupler LLC | 67046-1639 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-949 |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-8713 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | NuCare Pharmaceuticals, Inc. | 68071-3803 |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-8727 |